CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
40.53
+0.23 (0.57%)
At close: Jan 17, 2025, 4:00 PM
41.35
+0.82 (2.02%)
Pre-market: Jan 21, 2025, 5:43 AM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $3.46 billion as of January 21, 2025. Its market cap has decreased by -30.39% in one year.
Market Cap
3.46B
Enterprise Value
1.75B
1-Year Change
-30.39%
Ranking
Category
Stock Price
$40.53
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.46B, an increase of 517.64%. That is a compound annual growth rate of 24.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.46B | 2.97% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |